blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3919505

EP3919505 - USES OF CAS9-NUCLEIC ACID COMPLEXES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.07.2024
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  28.07.2023
FormerGrant of patent is intended
Status updated on  28.03.2023
FormerRequest for examination was made
Status updated on  10.06.2022
FormerThe application has been published
Status updated on  05.11.2021
Most recent event   Tooltip30.08.2024Lapse of the patent in a contracting state
New state(s): MC
published on 02.10.2024 [2024/40]
Applicant(s)For all designated states
Emory University
Office of Technology Transfer
1599 Clifton Road NE, 4th Floor
Atlanta, GA 30322 / US
[2021/49]
Inventor(s)01 / WEISS, David S.
Decatur, GA 30032 / US
02 / GRAKOUI, Arash
Decatur, GA 30033 / US
03 / SAMPSON, Timothy
Atlanta, GA 30329 / US
04 / PRICE, Aryn Alaine
Atlanta, GA 30322 / US
 [2021/49]
Representative(s)Lau, Sarah Jane, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2021/49]
Application number, filing date21175562.415.01.2014
[2021/49]
Priority number, dateUS201361753046P16.01.2013         Original published format: US 201361753046 P
US201361905368P18.11.2013         Original published format: US 201361905368 P
[2021/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3919505
Date:08.12.2021
Language:EN
[2021/49]
Type: B1 Patent specification 
No.:EP3919505
Date:30.08.2023
Language:EN
[2023/35]
Search report(s)(Supplementary) European search report - dispatched on:EP05.11.2021
ClassificationIPC:C07K14/195, C12N9/22, C12N15/113, C12N15/90
[2021/49]
CPC:
C07K14/195 (EP,US); C12N9/16 (US); A61K39/00 (EP,US);
A61K39/0011 (EP,US); C12N15/1131 (EP); C12N15/8213 (EP,US);
C12N15/8216 (EP,US); C12N15/8218 (EP,US); C12N15/902 (EP,US);
C12N9/22 (EP,US); C12Y301/21004 (EP,US); A61K2035/11 (EP);
A61K2039/5156 (EP,US); A61K2039/523 (EP); C07K2319/42 (EP,US);
C07K2319/85 (EP,US); C12N2310/20 (EP); C12N2800/22 (EP,US);
Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/28]  
Former [2021/49]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:VERWENDUNGEN VON CAS9-NUKLEINSÄUREKOMPLEXEN[2021/49]
English:USES OF CAS9-NUCLEIC ACID COMPLEXES[2021/49]
French:UTILISATIONS DES COMPLEXES D'ACIDE NUCLÉIQUE CAS9[2021/49]
Examination procedure06.06.2022Amendment by applicant (claims and/or description)
06.06.2022Examination requested  [2022/28]
06.06.2022Date on which the examining division has become responsible
29.03.2023Communication of intention to grant the patent
21.07.2023Fee for grant paid
21.07.2023Fee for publishing/printing paid
21.07.2023Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14740738.1  / EP2946015
Opposition(s)03.06.2024No opposition filed within time limit [2024/32]
Fees paidRenewal fee
24.05.2021Renewal fee patent year 03
24.05.2021Renewal fee patent year 04
24.05.2021Renewal fee patent year 05
24.05.2021Renewal fee patent year 06
24.05.2021Renewal fee patent year 07
24.05.2021Renewal fee patent year 08
27.01.2022Renewal fee patent year 09
27.01.2023Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ30.08.2023
ES30.08.2023
HR30.08.2023
MC30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
[2024/40]
Former [2024/23]CZ30.08.2023
ES30.08.2023
HR30.08.2023
PL30.08.2023
RO30.08.2023
RS30.08.2023
SK30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/20]HR30.08.2023
PL30.08.2023
RS30.08.2023
SM30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/10]HR30.08.2023
PL30.08.2023
RS30.08.2023
NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/09]NO30.11.2023
GR01.12.2023
IS30.12.2023
Former [2024/08]NO30.11.2023
GR01.12.2023
Cited inby applicantEP0122791
 US4536475
 US4693977
 US4886937
 US4959317
 US5015580
 US5110732
 US5302523
 US5459252
 US5464765
 US5501967
 US5508184
 US5527695
 US5538880
 US5550318
 US5563055
 US5591616
 US5618682
 US5674713
 US5693512
 US5824877
 US5837848
 US5976796
 US5981840
 US6074859
 US6160208
 US6384301
 US6399861
 US6403865
 WO2006073727
 US2006200878
 WO2007025097
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.